Novartis AG Operating Income 2010-2024 | NVS

Novartis AG operating income for the twelve months ending December 31, 2024 was $14.544B, a 48.88% increase year-over-year.

  • Novartis AG annual operating income for 2024 was $14.544B, a 48.88% increase from 2023.
  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.

Novartis AG Operating Income 2010-2024 | NVS

  • Novartis AG annual operating income for 2024 was $14.544B, a 48.88% increase from 2023.
  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B